Clinical consequences of acrylic intraocular lens material and design: Nd:YAG-laser capsulotomy rates in 3 x 300 eyes 5 years after phacoemulsification
Identifieur interne : 004107 ( Istex/Corpus ); précédent : 004106; suivant : 004108Clinical consequences of acrylic intraocular lens material and design: Nd:YAG-laser capsulotomy rates in 3 x 300 eyes 5 years after phacoemulsification
Auteurs : Björn JohanssonSource :
- British Journal of Ophthalmology [ 0007-1161 ] ; 2010-04.
Abstract
Background/aims To investigate the incidence of Nd:YAG-laser treatment for posterior capsular opacification (PCO) over a period of 5 years from phacoemulsification in an unselected population, comparing outcomes for three acrylic intraocular lenses (IOLs). Methods Retrospective longitudinal cohort study comprising 900 eyes. Three subgroups of 300 eyes, receiving the AR40, AR40e (Abbott Medical Optics, Santa Ana, California), or BL27 (Bausch & Lomb, Rochester, New York) IOL respectively, were compared. Data on patient age, gender, IOL type, dates of cataract surgery, Nd:YAG-laser treatment and/or death, and visual acuities before/after cataract surgery/Nd:YAG-laser treatment were collected from five sources: cataract operation register, patient administration system, quality control system for cataract operations, Nd:YAG-laser treatment register and clinical patient records. Results 216 eyes (24%) received Nd:YAG-laser treatment over a 5-year period. Statistically significant differences (p<0.001, χ2 test) were found between treatment rates for the three IOLs: AR40 73 eyes (24%), BL27 91 eyes (30%) and AR40e 52 eyes (17%). Eyes of patients who died during the follow-up period had fewer treatments (23/266, 8.6%) than eyes of patients living (193/634, 30%) at the end of the follow-up period. Conclusion In comparison with a hydrophobic acrylic IOL with sharp posterior optic edge, a hydrophilic acrylic IOL was associated with almost twice the number of Nd:YAG-laser treatments over the 5-year period. The results are useful for discussing the economic long-term consequences of choosing an IOL with a design that makes PCO development more or less likely. Caution is advised when applying data from post-mortem PCO studies on living populations.
Url:
DOI: 10.1136/bjo.2009.166181
Links to Exploration step
ISTEX:572C62E9B3FFBEB26E8BEA65953AC30765323608Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Clinical consequences of acrylic intraocular lens material and design: Nd:YAG-laser capsulotomy rates in 3 x 300 eyes 5 years after phacoemulsification</title><author wicri:is="90%"><name sortKey="Johansson, Bjorn" sort="Johansson, Bjorn" uniqKey="Johansson B" first="Björn" last="Johansson">Björn Johansson</name><affiliation><mods:affiliation>E-mail: bjorn.johansson@lio.se</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:572C62E9B3FFBEB26E8BEA65953AC30765323608</idno><date when="2010" year="2010">2010</date><idno type="doi">10.1136/bjo.2009.166181</idno><idno type="url">https://api.istex.fr/document/572C62E9B3FFBEB26E8BEA65953AC30765323608/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">004107</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Clinical consequences of acrylic intraocular lens material and design: Nd:YAG-laser capsulotomy rates in 3 x 300 eyes 5 years after phacoemulsification</title><author wicri:is="90%"><name sortKey="Johansson, Bjorn" sort="Johansson, Bjorn" uniqKey="Johansson B" first="Björn" last="Johansson">Björn Johansson</name><affiliation><mods:affiliation>E-mail: bjorn.johansson@lio.se</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">British Journal of Ophthalmology</title><title level="j" type="abbrev">Br J Ophthalmol</title><idno type="ISSN">0007-1161</idno><idno type="eISSN">1468-2079</idno><imprint><publisher>BMJ Publishing Group Ltd.</publisher><pubPlace>BMA House, Tavistock Square, London, WC1H 9JR</pubPlace><date type="published" when="2010-04">2010-04</date><biblScope unit="volume">94</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="450">450</biblScope></imprint><idno type="ISSN">0007-1161</idno></series><idno type="istex">572C62E9B3FFBEB26E8BEA65953AC30765323608</idno><idno type="DOI">10.1136/bjo.2009.166181</idno><idno type="href">bjophthalmol-94-450.pdf</idno><idno type="ArticleID">bjo166181</idno><idno type="PMID">19828518</idno><idno type="local">bjophthalmol;94/4/450</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0007-1161</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Background/aims To investigate the incidence of Nd:YAG-laser treatment for posterior capsular opacification (PCO) over a period of 5 years from phacoemulsification in an unselected population, comparing outcomes for three acrylic intraocular lenses (IOLs). Methods Retrospective longitudinal cohort study comprising 900 eyes. Three subgroups of 300 eyes, receiving the AR40, AR40e (Abbott Medical Optics, Santa Ana, California), or BL27 (Bausch & Lomb, Rochester, New York) IOL respectively, were compared. Data on patient age, gender, IOL type, dates of cataract surgery, Nd:YAG-laser treatment and/or death, and visual acuities before/after cataract surgery/Nd:YAG-laser treatment were collected from five sources: cataract operation register, patient administration system, quality control system for cataract operations, Nd:YAG-laser treatment register and clinical patient records. Results 216 eyes (24%) received Nd:YAG-laser treatment over a 5-year period. Statistically significant differences (p<0.001, χ2 test) were found between treatment rates for the three IOLs: AR40 73 eyes (24%), BL27 91 eyes (30%) and AR40e 52 eyes (17%). Eyes of patients who died during the follow-up period had fewer treatments (23/266, 8.6%) than eyes of patients living (193/634, 30%) at the end of the follow-up period. Conclusion In comparison with a hydrophobic acrylic IOL with sharp posterior optic edge, a hydrophilic acrylic IOL was associated with almost twice the number of Nd:YAG-laser treatments over the 5-year period. The results are useful for discussing the economic long-term consequences of choosing an IOL with a design that makes PCO development more or less likely. Caution is advised when applying data from post-mortem PCO studies on living populations.</div></front></TEI><istex><corpusName>bmj</corpusName><author><json:item><name>Björn Johansson</name><affiliations><json:string>E-mail: bjorn.johansson@lio.se</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Unlocked</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Posterior capsular opacification</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>phacoemulsification</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Nd-YAG lasers</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>longitudinal survey</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>retrospective study</value></json:item></subject><articleId><json:string>bjo166181</json:string></articleId><language><json:string>eng</json:string></language><abstract>Background/aims To investigate the incidence of Nd:YAG-laser treatment for posterior capsular opacification (PCO) over a period of 5 years from phacoemulsification in an unselected population, comparing outcomes for three acrylic intraocular lenses (IOLs). Methods Retrospective longitudinal cohort study comprising 900 eyes. Three subgroups of 300 eyes, receiving the AR40, AR40e (Abbott Medical Optics, Santa Ana, California), or BL27 (Bausch & Lomb, Rochester, New York) IOL respectively, were compared. Data on patient age, gender, IOL type, dates of cataract surgery, Nd:YAG-laser treatment and/or death, and visual acuities before/after cataract surgery/Nd:YAG-laser treatment were collected from five sources: cataract operation register, patient administration system, quality control system for cataract operations, Nd:YAG-laser treatment register and clinical patient records. Results 216 eyes (24%) received Nd:YAG-laser treatment over a 5-year period. Statistically significant differences (p>0.001, χ2 test) were found between treatment rates for the three IOLs: AR40 73 eyes (24%), BL27 91 eyes (30%) and AR40e 52 eyes (17%). Eyes of patients who died during the follow-up period had fewer treatments (23/266, 8.6%) than eyes of patients living (193/634, 30%) at the end of the follow-up period. Conclusion In comparison with a hydrophobic acrylic IOL with sharp posterior optic edge, a hydrophilic acrylic IOL was associated with almost twice the number of Nd:YAG-laser treatments over the 5-year period. The results are useful for discussing the economic long-term consequences of choosing an IOL with a design that makes PCO development more or less likely. Caution is advised when applying data from post-mortem PCO studies on living populations.</abstract><qualityIndicators><score>7.175</score><pdfVersion>1.4</pdfVersion><pdfPageSize>595.276 x 793.701 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>6</keywordCount><abstractCharCount>1764</abstractCharCount><pdfWordCount>3687</pdfWordCount><pdfCharCount>24848</pdfCharCount><pdfPageCount>6</pdfPageCount><abstractWordCount>249</abstractWordCount></qualityIndicators><title>Clinical consequences of acrylic intraocular lens material and design: Nd:YAG-laser capsulotomy rates in 3 x 300 eyes 5 years after phacoemulsification</title><pmid><json:string>19828518</json:string></pmid><genre.original><json:string>research-article</json:string></genre.original><genre><json:string>research-article</json:string></genre><host><volume>94</volume><publisherId><json:string>bjo</json:string></publisherId><pages><first>450</first></pages><issn><json:string>0007-1161</json:string></issn><issue>4</issue><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1468-2079</json:string></eissn><title>British Journal of Ophthalmology</title></host><publicationDate>2010</publicationDate><copyrightDate>2010</copyrightDate><doi><json:string>10.1136/bjo.2009.166181</json:string></doi><id>572C62E9B3FFBEB26E8BEA65953AC30765323608</id><score>1</score><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/572C62E9B3FFBEB26E8BEA65953AC30765323608/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/572C62E9B3FFBEB26E8BEA65953AC30765323608/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/572C62E9B3FFBEB26E8BEA65953AC30765323608/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a">Clinical consequences of acrylic intraocular lens material and design: Nd:YAG-laser capsulotomy rates in 3 x 300 eyes 5 years after phacoemulsification</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>BMJ Publishing Group Ltd.</publisher><pubPlace>BMA House, Tavistock Square, London, WC1H 9JR</pubPlace><availability><p>BMJ</p></availability><date>2009-10-14</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a">Clinical consequences of acrylic intraocular lens material and design: Nd:YAG-laser capsulotomy rates in 3 x 300 eyes 5 years after phacoemulsification</title><author><persName><forename type="first">Björn</forename><surname>Johansson</surname></persName><email>bjorn.johansson@lio.se</email></author></analytic><monogr><title level="j">British Journal of Ophthalmology</title><title level="j" type="abbrev">Br J Ophthalmol</title><idno type="pISSN">0007-1161</idno><idno type="eISSN">1468-2079</idno><imprint><publisher>BMJ Publishing Group Ltd.</publisher><pubPlace>BMA House, Tavistock Square, London, WC1H 9JR</pubPlace><date type="published" when="2010-04"></date><biblScope unit="volume">94</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="450">450</biblScope></imprint></monogr><idno type="istex">572C62E9B3FFBEB26E8BEA65953AC30765323608</idno><idno type="DOI">10.1136/bjo.2009.166181</idno><idno type="href">bjophthalmol-94-450.pdf</idno><idno type="ArticleID">bjo166181</idno><idno type="PMID">19828518</idno><idno type="local">bjophthalmol;94/4/450</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2009-10-14</date></creation><langUsage><language ident="en">en</language></langUsage><abstract><p>Background/aims To investigate the incidence of Nd:YAG-laser treatment for posterior capsular opacification (PCO) over a period of 5 years from phacoemulsification in an unselected population, comparing outcomes for three acrylic intraocular lenses (IOLs). Methods Retrospective longitudinal cohort study comprising 900 eyes. Three subgroups of 300 eyes, receiving the AR40, AR40e (Abbott Medical Optics, Santa Ana, California), or BL27 (Bausch & Lomb, Rochester, New York) IOL respectively, were compared. Data on patient age, gender, IOL type, dates of cataract surgery, Nd:YAG-laser treatment and/or death, and visual acuities before/after cataract surgery/Nd:YAG-laser treatment were collected from five sources: cataract operation register, patient administration system, quality control system for cataract operations, Nd:YAG-laser treatment register and clinical patient records. Results 216 eyes (24%) received Nd:YAG-laser treatment over a 5-year period. Statistically significant differences (p<0.001, χ2 test) were found between treatment rates for the three IOLs: AR40 73 eyes (24%), BL27 91 eyes (30%) and AR40e 52 eyes (17%). Eyes of patients who died during the follow-up period had fewer treatments (23/266, 8.6%) than eyes of patients living (193/634, 30%) at the end of the follow-up period. Conclusion In comparison with a hydrophobic acrylic IOL with sharp posterior optic edge, a hydrophilic acrylic IOL was associated with almost twice the number of Nd:YAG-laser treatments over the 5-year period. The results are useful for discussing the economic long-term consequences of choosing an IOL with a design that makes PCO development more or less likely. Caution is advised when applying data from post-mortem PCO studies on living populations.</p></abstract><textClass><keywords scheme="keyword"><list><head>hwp-journal-coll</head><item><term>Unlocked</term></item></list></keywords></textClass><textClass><keywords scheme="keyword"><list><head>Keywords</head><item><term>Posterior capsular opacification</term></item><item><term>phacoemulsification</term></item><item><term>Nd-YAG lasers</term></item><item><term>longitudinal survey</term></item><item><term>retrospective study</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2009-10-14">Created</change><change when="2010-04">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/572C62E9B3FFBEB26E8BEA65953AC30765323608/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="corpus bmj" wicri:toSee="no header"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="no"</istex:xmlDeclaration><istex:docType PUBLIC="-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" URI="archivearticle.dtd" name="istex:docType"></istex:docType><istex:document><article article-type="research-article"><front><journal-meta><journal-id journal-id-type="hwp">bjophthalmol</journal-id><journal-id journal-id-type="nlm-ta">Br J Ophthalmol</journal-id><journal-id journal-id-type="publisher-id">bjo</journal-id><journal-title>British Journal of Ophthalmology</journal-title><abbrev-journal-title abbrev-type="publisher">Br J Ophthalmol</abbrev-journal-title><abbrev-journal-title>Br J Ophthalmol</abbrev-journal-title><issn pub-type="ppub">0007-1161</issn><issn pub-type="epub">1468-2079</issn><publisher><publisher-name>BMJ Publishing Group Ltd.</publisher-name><publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">bjo166181</article-id><article-id pub-id-type="doi">10.1136/bjo.2009.166181</article-id><article-id pub-id-type="other">bjophthalmol;94/4/450</article-id><article-id pub-id-type="other">bjophthalmol;bjo.2009.166181</article-id><article-id pub-id-type="pmid">19828518</article-id><article-id pub-id-type="other">450</article-id><article-id pub-id-type="other">bjo.2009.166181</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical science</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Unlocked</subject></subj-group></article-categories><title-group><article-title>Clinical consequences of acrylic intraocular lens material and design: Nd:YAG-laser capsulotomy rates in 3 x 300 eyes 5 years after phacoemulsification</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Johansson</surname><given-names>Björn</given-names></name></contrib></contrib-group><author-notes><corresp><label>Correspondence to</label> Dr Björn Johansson, Department of Ophthalmology, Linköping University Hospital, SE 581 85 Linköping, Sweden; <email>bjorn.johansson@lio.se</email></corresp></author-notes><pub-date pub-type="epub-original"><day>14</day><month>10</month><year>2009</year></pub-date><pub-date pub-type="ppub"><month>4</month><year>2010</year></pub-date><pub-date pub-type="epub"><day>14</day><month>10</month><year>2009</year></pub-date><volume>94</volume><volume-id pub-id-type="other">94</volume-id><volume-id pub-id-type="other">94</volume-id><issue>4</issue><issue-id pub-id-type="other">bjophthalmol;94/4</issue-id><issue-id pub-id-type="other">4</issue-id><issue-id pub-id-type="other">94/4</issue-id><fpage>450</fpage><history><date date-type="accepted"><day>5</day><month>9</month><year>2009</year></date></history><permissions><copyright-statement>© 2010, Published by the BMJ Publishing Group Limited For permission to use, (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</copyright-statement><copyright-year>2010</copyright-year><license license-type="open-access"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/2.0/">http://creativecommons.org/licenses/by-nc/2.0/</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/2.0/legalcode">http://creativecommons.org/licenses/by-nc/2.0/legalcode</ext-link>.</p></license></permissions><self-uri content-type="pdf" xlink:role="full-text" xlink:href="bjophthalmol-94-450.pdf"></self-uri><abstract><sec><title>Background/aims</title><p>To investigate the incidence of Nd:YAG-laser treatment for posterior capsular opacification (PCO) over a period of 5 years from phacoemulsification in an unselected population, comparing outcomes for three acrylic intraocular lenses (IOLs).</p></sec><sec><title>Methods</title><p>Retrospective longitudinal cohort study comprising 900 eyes. Three subgroups of 300 eyes, receiving the AR40, AR40e (Abbott Medical Optics, Santa Ana, California), or BL27 (Bausch & Lomb, Rochester, New York) IOL respectively, were compared. Data on patient age, gender, IOL type, dates of cataract surgery, Nd:YAG-laser treatment and/or death, and visual acuities before/after cataract surgery/Nd:YAG-laser treatment were collected from five sources: cataract operation register, patient administration system, quality control system for cataract operations, Nd:YAG-laser treatment register and clinical patient records.</p></sec><sec><title>Results</title><p>216 eyes (24%) received Nd:YAG-laser treatment over a 5-year period. Statistically significant differences (p<0.001, χ<sup>2</sup> test) were found between treatment rates for the three IOLs: AR40 73 eyes (24%), BL27 91 eyes (30%) and AR40e 52 eyes (17%). Eyes of patients who died during the follow-up period had fewer treatments (23/266, 8.6%) than eyes of patients living (193/634, 30%) at the end of the follow-up period.</p></sec><sec><title>Conclusion</title><p>In comparison with a hydrophobic acrylic IOL with sharp posterior optic edge, a hydrophilic acrylic IOL was associated with almost twice the number of Nd:YAG-laser treatments over the 5-year period. The results are useful for discussing the economic long-term consequences of choosing an IOL with a design that makes PCO development more or less likely. Caution is advised when applying data from post-mortem PCO studies on living populations.</p></sec></abstract><kwd-group><kwd>Posterior capsular opacification</kwd><kwd>phacoemulsification</kwd><kwd>Nd-YAG lasers</kwd><kwd>longitudinal survey</kwd><kwd>retrospective study</kwd></kwd-group></article-meta></front></article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo><title>Clinical consequences of acrylic intraocular lens material and design: Nd:YAG-laser capsulotomy rates in 3 x 300 eyes 5 years after phacoemulsification</title></titleInfo><titleInfo type="alternative" contentType="CDATA"><title>Clinical consequences of acrylic intraocular lens material and design: Nd:YAG-laser capsulotomy rates in 3 x 300 eyes 5 years after phacoemulsification</title></titleInfo><name type="personal"><namePart type="given">Björn</namePart><namePart type="family">Johansson</namePart><affiliation>E-mail: bjorn.johansson@lio.se</affiliation></name><typeOfResource>text</typeOfResource><genre type="research-article" displayLabel="research-article"></genre><subject><genre>hwp-journal-coll</genre><topic>Unlocked</topic></subject><originInfo><publisher>BMJ Publishing Group Ltd.</publisher><place><placeTerm type="text">BMA House, Tavistock Square, London, WC1H 9JR</placeTerm></place><dateIssued encoding="w3cdtf">2010-04</dateIssued><dateCreated encoding="w3cdtf">2009-10-14</dateCreated><copyrightDate encoding="w3cdtf">2010</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract>Background/aims To investigate the incidence of Nd:YAG-laser treatment for posterior capsular opacification (PCO) over a period of 5 years from phacoemulsification in an unselected population, comparing outcomes for three acrylic intraocular lenses (IOLs). Methods Retrospective longitudinal cohort study comprising 900 eyes. Three subgroups of 300 eyes, receiving the AR40, AR40e (Abbott Medical Optics, Santa Ana, California), or BL27 (Bausch & Lomb, Rochester, New York) IOL respectively, were compared. Data on patient age, gender, IOL type, dates of cataract surgery, Nd:YAG-laser treatment and/or death, and visual acuities before/after cataract surgery/Nd:YAG-laser treatment were collected from five sources: cataract operation register, patient administration system, quality control system for cataract operations, Nd:YAG-laser treatment register and clinical patient records. Results 216 eyes (24%) received Nd:YAG-laser treatment over a 5-year period. Statistically significant differences (p<0.001, χ2 test) were found between treatment rates for the three IOLs: AR40 73 eyes (24%), BL27 91 eyes (30%) and AR40e 52 eyes (17%). Eyes of patients who died during the follow-up period had fewer treatments (23/266, 8.6%) than eyes of patients living (193/634, 30%) at the end of the follow-up period. Conclusion In comparison with a hydrophobic acrylic IOL with sharp posterior optic edge, a hydrophilic acrylic IOL was associated with almost twice the number of Nd:YAG-laser treatments over the 5-year period. The results are useful for discussing the economic long-term consequences of choosing an IOL with a design that makes PCO development more or less likely. Caution is advised when applying data from post-mortem PCO studies on living populations.</abstract><subject><genre>Keywords</genre><topic>Posterior capsular opacification</topic><topic>phacoemulsification</topic><topic>Nd-YAG lasers</topic><topic>longitudinal survey</topic><topic>retrospective study</topic></subject><relatedItem type="host"><titleInfo><title>British Journal of Ophthalmology</title></titleInfo><titleInfo type="abbreviated"><title>Br J Ophthalmol</title></titleInfo><genre type="Journal">journal</genre><identifier type="ISSN">0007-1161</identifier><identifier type="eISSN">1468-2079</identifier><identifier type="PublisherID">bjo</identifier><identifier type="PublisherID-hwp">bjophthalmol</identifier><identifier type="PublisherID-nlm-ta">Br J Ophthalmol</identifier><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>94</number></detail><detail type="issue"><caption>no.</caption><number>4</number></detail><extent unit="pages"><start>450</start></extent></part></relatedItem><identifier type="istex">572C62E9B3FFBEB26E8BEA65953AC30765323608</identifier><identifier type="DOI">10.1136/bjo.2009.166181</identifier><identifier type="href">bjophthalmol-94-450.pdf</identifier><identifier type="ArticleID">bjo166181</identifier><identifier type="PMID">19828518</identifier><identifier type="local">bjophthalmol;94/4/450</identifier><accessCondition type="use and reproduction" contentType="open-access">This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.</accessCondition><recordInfo><recordContentSource>BMJ</recordContentSource></recordInfo></mods></metadata><annexes><json:item><original>true</original><mimetype>image/jpeg</mimetype><extension>jpeg</extension><uri>https://api.istex.fr/document/572C62E9B3FFBEB26E8BEA65953AC30765323608/annexes/jpeg</uri></json:item></annexes><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/HapticV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004107 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 004107 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Ticri/CIDE
|area= HapticV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:572C62E9B3FFBEB26E8BEA65953AC30765323608
|texte= Clinical consequences of acrylic intraocular lens material and design: Nd:YAG-laser capsulotomy rates in 3 x 300 eyes 5 years after phacoemulsification
}}
| This area was generated with Dilib version V0.6.23. |  |